ESC 2022 Symposium

When your heart failure patient becomes problematic

Click below to watch your session of interest.

What signs of advanced heart failure require treatment escalation?
K. Witte (Leeds, UK)

How do I manage my patient with functional mitral regurgitation?
R.S. Von Bardeleben (Mainz, DE)

How monitoring and controlling pulmonary artery pressures can benefit my patient?
A. Bayes Genis (Badalona, ES)

When is long-term mechanical circulatory support an option while evaluating your patient for HTx?
S. Nalbantgil (Izmir, TR)

What signs of advanced heart failure require treatment escalation?

K. Witte (Leeds, UK)

How do I manage my patient with functional mitral regurgitation?

R.S. Von Bardeleben (Mainz, DE)

How monitoring and controlling pulmonary artery pressures can benefit my patient?

A. Bayes Genis (Badalona, ES)

When is long-term mechanical circulatory support an option while evaluating your patient for HTx?

S. Nalbantgil (Izmir, TR)

The content in the sessions represents the opinions of the participants and contributors to the symposium. Statements or clinical cases presented or discussed reflect the clinical judgement of the physicians. As a consequence, Abbott accepts no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither does Abbott endorse the content or the use of a device in a way that lies outside its current licensed application in any territory.

© Abbott 2022. All rights reserved. 9-EH-5-13618-01 09-2022

Sie verlassen jetzt AdvancedHeartTherapies.com

Sie verlassen jetzt AdvancedHeartTherapies.com. Abbott ist nicht verantwortlich für die Inhalte, die auf der Website Dritter veröffentlicht sind, auf die Sie jetzt zugreifen werden. Abbott hat die auf Websites Dritter veröffentlichen Informationen nicht geprüft und unterstützt diese nicht.